Tag: generic drug approval
-
4 Feb
-
28 Dec
Deficiency Letters in Generic Applications: Common FDA Findings and How to Avoid Them
Deficiency letters from the FDA are the most common reason generic drug applications are delayed. Learn the top 5 findings-dissolution issues, impurities, sameness problems, CQAs, and bioequivalence errors-and how to avoid them before submitting your ANDA.